Capitale Di Prestito Cambiamento Data
AstraZeneca USD 26.01B 46M 2026-06
Genmab DKK 4.96B 28M 2026-06
GlaxoSmithKline GBP 13.95B 65M 2026-06
GRIFOLS EUR 7.17B 1.91B 2026-06
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lakefront Biotherapeutics EUR 4.77M 78K 2026-06
Qiagen NV USD 1.63B 19.45M 2026-06
UCB EUR 2.18B 634M 2025-12